Integra Lifesciences Holdings (IART) Income from Continuing Operations (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Income from Continuing Operations of 4482000.0 for Q2 2026, up 197.08% sequentially from 4617000.0 in Q1 2026, and up 100.93% YoY from 2230673.17 in Q2 2025.
Integra Lifesciences Holdings (IART) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Income from Continuing Operations for 18 years, with the latest figure at 4482000.0 in Q2 2026.
- Quarterly Income from Continuing Operations rose 100.93% year-over-year to 4482000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 7243000.0 (up 98.55% YoY) and the FY2025 annual result came in at 516474000.0, down 7337.7% from the prior year.
- Income from Continuing Operations climbed to 4482000.0 in Q2 2026 per IART's latest filing, from 4617000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 52946000.0 in Q4 2022 and troughed at 484073000.0 in Q2 2025.
- A 5-year average of 15292277.78 and a median of 4333000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2025 and 2026: Income from Continuing Operations slumped 3803.18% in 2025, then soared 100.93% in 2026.
- Over 5 years, Income from Continuing Operations stood at 52946000.0 in 2022, then plunged by 62.54% to 19834000.0 in 2023, then dropped by 2.01% to 19435000.0 in 2024, then sank by 108.77% to 1704000.0 in 2025, then soared by 363.03% to 4482000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 4482000.0, 4617000.0, and 1704000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Integra Lifesciences Holdings | 1.32 Bn | 1.05 Bn | 219.74 Mn | 4.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.48 Mn |
| Mar 31, 2026 | -4.62 Mn |
| Dec 31, 2025 | -1.70 Mn |
| Sep 30, 2025 | -5.40 Mn |
| Jun 30, 2025 | -484.07 Mn |
| Mar 31, 2025 | -25.29 Mn |
| Dec 31, 2024 | 19.44 Mn |
| Sep 30, 2024 | -10.70 Mn |
| Jun 30, 2024 | -12.40 Mn |
| Mar 31, 2024 | -3.28 Mn |
| Dec 31, 2023 | 19.83 Mn |
| Sep 30, 2023 | 19.50 Mn |
| Jun 30, 2023 | 4.18 Mn |
| Mar 31, 2023 | 24.23 Mn |
| Dec 31, 2022 | 52.95 Mn |
| Sep 30, 2022 | 49.92 Mn |
| Jun 30, 2022 | 44.79 Mn |
| Mar 31, 2022 | 32.90 Mn |
| Dec 31, 2021 | 45.38 Mn |
| Sep 30, 2021 | 43.23 Mn |